These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20479548)

  • 1. Effect of inhomogeneities and source position on dose distribution of nucletron high dose rate Ir-192 brachytherapy source by Monte Carlo simulation.
    Chandola RM; Tiwari S; Kowar MK; Choudhary V
    J Cancer Res Ther; 2010; 6(1):54-7. PubMed ID: 20479548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo study of dosimetric parameters and dose distribution effect of inhomogeneities and source position of GammaMed Plus source.
    Chandola RM; Tiwari S; Painuly NK; Choudhary V; Azad SK; Beck M
    J Cancer Res Ther; 2011; 7(1):29-34. PubMed ID: 21546739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental and Monte Carlo study of the effect of the presence of dry air, cortical bone inhomogeneities and source position on dose distribution of the mHDR-v2 source.
    Chandola RM; Tiwari S; Beck M; Chandrakar PK; Thakur SK
    J Cancer Res Ther; 2012; 8(4):555-60. PubMed ID: 23361274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte Carlo dosimetry of the microselectron HDR 192Ir brachytherapy source using MCNP4A.
    Wallace S; Wong T; Fernando W
    Australas Phys Eng Sci Med; 1998 Mar; 21(1):11-7. PubMed ID: 9633148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
    Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
    Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of rib and lung heterogeneities on the computed dose to lung in Ir-192 high-dose-rate breast brachytherapy: Monte Carlo versus a treatment planning system.
    Yazdi HS; Shamsaei M; Jaberi R; Shabani HR; Allahverdi M; Vaezzadeh SA
    J Cancer Res Ther; 2012; 8(3):394-8. PubMed ID: 23174721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a scatter correction technique and its application to HDR 192Ir multicatheter breast brachytherapy.
    Poon E; Verhaegen F
    Med Phys; 2009 Aug; 36(8):3703-13. PubMed ID: 19746803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo and experimental dosimetric study of the mHDR-v2 brachytherapy source.
    Chandola RM; Tiwari S; Kowar MK; Choudhary V
    J Cancer Res Ther; 2010; 6(4):421-6. PubMed ID: 21358074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
    Poon E; Verhaegen F
    Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dosimetric study of Leipzig applicators.
    Pérez-Calatayud J; Granero D; Ballester F; Puchades V; Casal E; Soriano A; Crispín V
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):579-84. PubMed ID: 15890603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An experimental MOSFET approach to characterize (192)Ir HDR source anisotropy.
    Toye WC; Das KR; Todd SP; Kenny MB; Franich RD; Johnston PN
    Phys Med Biol; 2007 Sep; 52(17):5329-39. PubMed ID: 17762089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.
    Pantelis E; Papagiannis P; Karaiskos P; Angelopoulos A; Anagnostopoulos G; Baltas D; Zamboglou N; Sakelliou L
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1596-602. PubMed ID: 15817368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurements of dose discrepancies due to inhomogeneities and radiographic contrast in balloon catheter brachytherapy.
    Oh S; Scott J; Shin DH; Suh TS; Kim S
    Med Phys; 2009 Sep; 36(9):3945-54. PubMed ID: 19810467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of patient inhomogeneities in oesophageal 192Ir HDR brachytherapy: a Monte Carlo and analytical dosimetry study.
    Anagnostopoulos G; Baltas D; Pantelis E; Papagiannis P; Sakelliou L
    Phys Med Biol; 2004 Jun; 49(12):2675-85. PubMed ID: 15272681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
    Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
    Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-specific Monte Carlo-based dose-kernel approach for inverse planning in afterloading brachytherapy.
    D'Amours M; Pouliot J; Dagnault A; Verhaegen F; Beaulieu L
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1582-9. PubMed ID: 21075547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The collapsed cone algorithm for (192)Ir dosimetry using phantom-size adaptive multiple-scatter point kernels.
    Tedgren ÅC; Plamondon M; Beaulieu L
    Phys Med Biol; 2015 Jul; 60(13):5313-23. PubMed ID: 26108232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part I: single sources and bounded homogeneous geometries.
    Zourari K; Pantelis E; Moutsatsos A; Petrokokkinos L; Karaiskos P; Sakelliou L; Georgiou E; Papagiannis P
    Med Phys; 2010 Feb; 37(2):649-61. PubMed ID: 20229874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric characterization of an 192Ir brachytherapy source with the Monte Carlo code PENELOPE.
    Casado FJ; García-Pareja S; Cenizo E; Mateo B; Bodineau C; Galán P
    Phys Med; 2010; 26(3):132-9. PubMed ID: 20034828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a phantom to validate high-dose-rate brachytherapy treatment planning systems with heterogeneous algorithms.
    Moura ES; Micka JA; Hammer CG; Culberson WS; DeWerd LA; Rostelato ME; Zeituni CA
    Med Phys; 2015 Apr; 42(4):1566-74. PubMed ID: 25832047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.